Industry backlash may reshape EU compulsory pharma licensing reform: GlobalData
Express Pharma
AUGUST 20, 2023
There was a substantial backlash from major pharma trade associations and companies to the European Commission’s (EC) feedback initiative on the introduction of a pan-European compulsory license, which would allow for the invalidation of existing drug patents across the European Union (EU) in emergency situations. This could lead to further revision of the proposal, says GlobalData.
Let's personalize your content